Nordic PREdnisolon for VEstibular NeuriTis Study – an investigator-driven, triple blind, placebo controlled randomized trial
This research study is investigating if a common steroid medicine, prednisolone, can effectively treat vestibular neuritis. Vestibular neuritis is a condition that affects the balance nerve in your inner ear, often leading to sudden and severe dizziness, spinning sensations (vertigo), and difficulty with balance. We are comparing prednisolone to a placebo (a tablet with no active medicine) to understand if it significantly helps to reduce symptoms like dizziness and generally improve how people feel. The main thing we'll be looking at is how patients' dizziness symptoms change after six weeks. We'll also check other aspects of their balance and well-being at different times over a year. The aim is to find out if prednisolone could be a useful treatment for this condition.
At a glance
What is this study about?
This study is called the "Nordic PREdnisolon for VEstibular NeuriTis Study," but we can simply think of it as a study looking into a treatment for a condition called vestibular neuritis. Vestibular neuritis causes a sudden onset of vertigo (a spinning sensation), dizziness, and problems with balance. It happens when the nerve that sends balance information from your inner ear to your brain becomes inflamed.
In this study, researchers want to see if a medicine called prednisolone can help people recover from vestibular neuritis. Prednisolone is a type of steroid medicine that is already used for many other conditions to reduce inflammation. The study compares prednisolone with a 'placebo', which looks exactly like the real medicine but doesn't contain any active drug. This helps the researchers truly understand if prednisolone itself is making a difference, or if people might simply get better over time or because they believe they are taking medicine.
The main goal is to find out if people taking prednisolone have fewer dizziness symptoms after six weeks compared to those taking the placebo. Researchers will also look at other things, like how well people can walk and stand, their overall quality of life, and other balance measurements over several months. By carefully comparing these groups, the study hopes to determine if prednisolone could be a safe and effective treatment to help people with vestibular neuritis recover more quickly and feel better.
Key takeaways
- Tests if prednisolone helps with dizziness from vestibular neuritis.
- Compares prednisolone to a dummy pill (placebo).
- Focuses on improving dizziness symptoms after 6 weeks.
- Your participation helps improve treatment for others.
- Study lasts 12 months with various check-ups.
Who may be eligible?
To be part of this study, you need to be an adult, 18 years old or older. The study is open to both men and women.
There might be other health conditions or medicines you are taking that mean this study isn't right for you. The study team will check all of this to make sure it's safe and appropriate for you to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you recently been diagnosed with vestibular neuritis?
- Are you able to attend appointments over a 12-month period?
- Are you willing to take a study tablet daily?
- Are you comfortable with the possibility of receiving a placebo?
What does participation involve?
If you decide to take part, you will be randomly assigned to either receive the study medicine (prednisolone) or a dummy pill (placebo). Neither you nor your study doctor will know which you are taking – this is to make the results as fair as possible. You will take the tablets as directed by the study team.
Over the course of the study, you will have several appointments. These appointments will involve filling out questionnaires about your dizziness and how you're feeling. You may also have some simple balance tests, like walking or standing on different surfaces, and tests to check your inner ear function. These appointments will happen at 2 weeks, 6 weeks, 3 months, and 12 months after starting the study. The total duration of your participation, including follow-up, will be 12 months.
Potential risks and benefits
Locations (3)
- —UnverifiedSweden
- —UnverifiedDenmark
- —UnverifiedNorway
Common questions
What is vestibular neuritis?
Vestibular neuritis is an inner ear problem that causes sudden, severe dizziness or a spinning sensation, and balance issues, often due to inflammation of the balance nerve.
What is prednisolone?
Prednisolone is a steroid medicine often used to reduce inflammation in the body for many different conditions.
What is a 'placebo'?
A placebo is a dummy pill that looks like the real medicine but contains no active drug. It helps researchers compare the effects of the active medicine fairly.
Will I know if I'm getting the real medicine or the placebo?
No, neither you nor your doctor will know. This is a common and important practice in research to get unbiased results.
How long will I be involved in the study?
If you join, you will be followed for a total of 12 months, with several check-up appointments during that time.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.